Cargando…
Combination of Epithelial Growth Factor Receptor Blockers and CDK4/6 Inhibitor for Nasopharyngeal Carcinoma Treatment
SIMPLE SUMMARY: Our findings indicated that the EGF-EGFR pathway was highly activated in very young patients with recurrent or metastatic NPC. High EGFR expression in patients with metastatic NPC resulted in poor clinical outcomes. To examine whether the EGFR pathway serves as a therapeutic target f...
Autores principales: | Li, Hsin-Pai, Huang, Chen-Yang, Lui, Kar-Wai, Chao, Yin-Kai, Yeh, Chun-Nan, Lee, Li-Yu, Huang, Yenlin, Lin, Tung-Liang, Kuo, Yung-Chia, Huang, Mei-Yuan, Lai, Yi-Ru, Yeh, Yuan-Ming, Fan, Hsien-Chi, Lin, An-Chi, Hsieh, Jason Chia-Hsun, Chang, Kai-Ping, Lin, Chien-Yu, Wang, Hung-Ming, Chang, Yu-Sun, Hsu, Cheng-Lung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231497/ https://www.ncbi.nlm.nih.gov/pubmed/34204797 http://dx.doi.org/10.3390/cancers13122954 |
Ejemplares similares
-
Application of a patient-derived xenograft model in cytolytic viral activation therapy for nasopharyngeal carcinoma
por: Hsu, Cheng-Lung, et al.
Publicado: (2015) -
Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma
por: Hsu, Cheng-Lung, et al.
Publicado: (2018) -
Nasopharyngeal carcinoma patient-derived xenograft mouse models reveal potential drugs targeting cell cycle, mTOR, and autophagy pathways
por: Li, Hsin-Pai, et al.
Publicado: (2023) -
Correlation between overall survival and differential plasma and tissue tumor marker expression in nasopharyngeal carcinoma patients with different sites of organ metastasis
por: Wang, Hung-Ming, et al.
Publicado: (2016) -
Discovering the Clinical and Prognostic Role of Pan-Immune-Inflammation Values on Oral Cavity Squamous Cell Carcinoma
por: Yeh, Chia-Chi, et al.
Publicado: (2023)